Availability and variability in guidelines on diabetic retinopathy screening in Asian countries

British Journal of Ophthalmology

Volumn 101, Issue 10, 2017, Pages 1352-1360

  Wang, Louis Zizhao ^a,b   Cheung, Carol Y ^a,c   Tapp, Robyn J ^a,d,e   Hamzah, Haslina ^a   Tan, Gavin ^a   Ting, Daniel ^a   Lamoureux, Ecosse ^a,f   Wong, Tien Yin ^a,f  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Epidemiology; Retina

Indexed keywords

ANAMNESIS; ARTICLE; ASIA; BLINDNESS; COST CONTROL; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PATIENT REFERRAL; PERSONNEL SHORTAGE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTOCOL COMPLIANCE; SCREENING; SLIT LAMP MICROSCOPY; SYSTEMATIC REVIEW; VISUAL ACUITY; COMPLICATION; MASS SCREENING; PHOTOGRAPHY; RISK FACTOR; STANDARDS;

ASIA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS; MASS SCREENING; PHOTOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS;

EID: 85023162381     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2016-310002     Document Type: Article

References (95)

1. Cho NH, Whiting D, Forouhi N, et al. IDF Diabetes Atlas. International Diabetes Federation. 7th edn. 2015. http://www.diabetesatlas.org/component/attachments/? task=download&id=116 (accessed Nov 2016).
2. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema pathophysiology, screening, and novel therapies. Diabetes Care 2003;26:2653-64.
3. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
4. Stratton IM, Aldington SJ, Taylor DJ, et al. A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 2013;36:580-5.
5. Cheung N, Mitchell P, Wong TY. Diabetic Retinopathy. Lancet 2010(10):124-36.
6. Kiire CA, Porta M, Chong V. Medical management for the prevention and treatment of diabetic macular edema. Surv Ophthalmol 2013;58:459-65.
7. Pershing S, Enns EA, Matesic B, et al. Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med 2014;160:18-29.
8. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Jama 2009;301:2129-40.
9. Chan JC, Zhang Y, Ning G. Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol 2014;2:969-79.
10. Ruta LM, Magliano DJ, LeMesurier R, et al. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 2013;30:387-98.
11. Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009;116:461-7.
12. Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol 2009;93:429-34.
13. Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology 2009;116:311-18.
14. Mbanya JC. New diabetes figures in China: IDF press statement. International Diabetes Federation, 2010. http://www.idf.org/press-releases/idf-press-statementchina-study (accessed Nov 2016).
15. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 2000;6:43-52.
16. Battling the diabetes epidemic in China. George Clinical Scientific and Operational Excellence in Clinical Trials. 2016. http://www.georgeclinical.com/resources/research/ what-are-we-doing-about-the-diabetes-epidemic (accessed Nov 2016).
17. King H, Keuky L, Seng S, et al. Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet 2005;366:1633-9.
18. Hautala N, Aikkila R, Korpelainen J, et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol 2014;92:582-7.
19. Olafsdottir E, Andersson DK, Stefansson E. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease. Acta Ophthalmol Scand 2007;85:40-5.
20. Zoega GM, Gunnarsdóttir T, Björnsdóttir S, et al. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 2005;83:687-90.
21. Liew G, Michaelides M, Bunce C. A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010. BMJ Open 2014;4:e004015.
22. Wong TY, Aiello LP, Ferris F, et al. ICO Guidelines for Diabetic Eye Care (Updated 2017). International Council of Ophthalmology, 2017. http://www.icoph.org/ downloads/ICOGuidelinesforDiabeticEyeCare.pdf (accessed Nov 2016).
23. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. United Nations Statistics Division, 2016. http://unstats.un.org/unsd/methods/m49/m49regin.htm-asia (accessed Nov 2016).
24. World Population Prospects: The 2015 Revision, Key Findings and Advance Tables. United Nations, Department of Economic and Social Affairs, Population Division, 2015. https://esa.un.org/unpd/wpp/publications/files/key-findings-wpp-2015.pdf (accessed Nov 2016).
25. Chinese Ophthalmological Society RWG. Diagnosis and treatment guideline of diabetic retinopathy. Zhonghua Yan Ke Za Zhi 2014;50:851-65.
26. Liu L, Wu X, Liu L, et al. Prevalence of diabetic retinopathy in mainland China: a meta-analysis. PLoS ONE 2012;7:e45264.
27. Xie XW, Xu L, Jonas JB, et al. Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study. Eur J Ophthalmol 2009;19:91.
28. Hong Kong reference framework for diabetes care for adults in primary care settings. Primary Care, Hong Kong, 2013. http://www.pco.gov.hk/english/resource/ files/RF-DM-full.pdf (accessed Nov 2016).
29. Lian JX, Gangwani RA, McGhee SM, et al. Systematic screening for diabetic retinopathy (DR) in Hong Kong: prevalence of DR and visual impairment among diabetic population. Br J Ophthalmol 2016;100:151-5.
30. Tam VH, Lam EP, Chu BC, et al. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complicat 2009;23:185-93.
31. Treatment Guide for Diabetes. The Japan Diabetes Society 2014-2015. http://www. fa.kyorin.co.jp/jds/uploads/Treatment-Guide-for-Diabetes-2014-2015.pdf
32. Fukushima S, Nakagami T, Suto C, et al. Prevalence of retinopathy and its risk factors in a Japanese population. J Diabetes Investig 2013;4:349-54.
33. Screening of Diabetic Retinopathy. Ministry of Health, Malaysia 2011;(November 2016). http://www.acadmed.org.my/view-file.cfm?fileid=656
34. Goh P. Status of diabetic retinopathy among diabetics registered to the Diabetic Eye Registry, National Eye Database, 2007. Med J Malaysia 2008;63:24-8.
35. Diabetes Mellitus Guideline. Ministry of Health, Palestine. https://www.google.com. sg/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0ahUKEwjFmJ2f4M XQAhWLso8KHcp5DYkQFgg4MAU&url=http%3A%2F%2Ffamilymedicine.moh.gov. bh%2FSlideShow%2FDM.pps&usg=AFQjCNEdp6WMcRzs1aPTdNRey LZHhyNLZg&sig2=4jeM7xfEQZqs9pnv2YjXjQ&bvm=bv.139782543,d.c2I (accessed Nov 2016).
36. Shahin Y, Kapur A, Khader A, et al. Clinical Audit on the Provision of Diabetes Care in the Primary Care Setting by United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). J Diabetes Mellitus 2014;5:12.
37. Philippine practice guidelines on the diagnosis and management of diabetes mellitus. UNITE for Diabetes Philippines, 2014. http://obesity.org.ph/v4/wp-content/ uploads/2014/07/Diabetes-United-for-Diabetes-Phil.pdf (accessed Nov 2016).
38. Fajardo-Gomez M, Uy HS. Prevalence of diabetic retinopathy among diabetic patients in a tertiary hospital. Philipp J Ophthalmol 2005;30:178-80.
39. Guidelines for Diabetes. Ministry of Health, Kingdom of Saudi Arabia. 2013. http:// static.moh.gov.sa/internet-layouts/MOH/Internet/Guidlines/diabetes.pdf (accessed Nov 2016).
40. Al Ghamdi AH, Rabiu M, Hajar S, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Taif, Saudi Arabia. Br J Ophthalmol 2012;96:1168-72.
41. Diabetes mellitus clinical practice guidelines. Ministry of Health, Singapore 2014. https://www.moh.gov.sg/content/dam/moh-web/HPP/Doctors/cpg-medical/current/ 2014/diabetes-mellitus/cpg-Diabetes Mellitus Booklet-Jul2014.pdf (accessed: Nov 2016).
42. Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol 2015;99:1614-21.
43. Management of diabetes mellitus clinical practice guidelines. Sri Lanka College of Obstetricians & Gynaecologists, Sri Lanka. http://www.slcog.lk/img/guidelines/ Othernational Gidelines/Physicians/Book 1/Management of Diabetes Mellitus.pdf (accessed November 2016).
44. Katulanda P, Ranasinghe P, Jayawardena R. Prevalence of retinopathy among adults with self-reported diabetes mellitus: the Sri Lanka diabetes and Cardiovascular Study. BMC Ophthalmol 2014;14:1.
45. Satman I, Imamoglu S, Yilmaz C. Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up of Patients with Diabetes and its Complications. Turk J Endocrinol Metab 2010;14(Suppl 1):1-127.
46. Taş A, Bayraktar MZ, Erdem Ü, et al. Prevalence and risk factors for diabetic retinopathy in Turkey. Gulhane Med J 2005;47:164-74.
47. National diabetes guidelines. National Diabetes Committee, United Arab Emirates. 2009. cms2.selesti.com/media/NationalDiabetesGuidelinesUAE.pdf (accessed Nov 2016).
48. Al-Maskari F, El-Sadig M. Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol 2007;7:11.
49. Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
50. Harding S, Greenwood R, Aldington S, et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-71.
51. Tele diabetic retinopathy screening. National Eye Database, Malaysia. http://www. acrm.org.my/ned/teleDR.html (accessed Nov 2016).
52. Unwin N, Gan D, Mbanya JC, et al. IDF Diabetes Atlas. International Diabetes Federation. 4th edn. 2009. https://www.google.com.sg/url?sa=t&rct=j&q= &esrc=s&source=web&cd=1&ved=0ahUKEwimyLKZl7-QAhWDt48KHV9E BKIQFgggMAA&url=http%3A%2F%2Fwww.diabetesatlas.org%2Fcomponent% 2Fattachments%2F%3Ftask%3Ddownload%26id%3D75&usg= AFQjCNFLsTR9cTJvR-7ZJ-0Cb3DkixPhEg&sig2=3DOu3tgNdE-d-IURpyJicg (accessed Nov 2016).
53. He S, Guo Y, Li Z. [Epidemiologic study of diabetic retinopathy in Capital Steel Company]. Zhonghua Yan Ke Za Zhi 1997;33:381-3.
54. Raymond NT, Varadhan L, Reynold DR, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with White Europeans in the Community: a cross-sectional study. Diabetes Care 2009;32:410-15.
55. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-91.
56. Looker HC, Nyangoma SO, Cromie D, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 2012;55:2335-42.
57. Lee KMC, Sum WMR. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optom 2011;94:371-5.
58. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237-43.
59. Scanlon PH, Stratton IM, Bachmann MO, et al. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age. Diabet Med 2016;33:1655-8.
60. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
61. Pescosolido N, Campagna O, Barbato A. Diabetic retinopathy and pregnancy. Int Ophthalmol 2014;34:989-97.
62. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: The Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631-7.
63. Control D, Group CTR. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000;23:1084-91.
64. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy. Am J Obstet Gynecol 1992;166:1214-18.
65. Scanlon PH. Deterioration in Vision after Commencing Insulin Treatment: The Early Worsening Phenomenon, in HbA1c in Diabetes: Case Studies using IFCC Units. Eds, S Gough, S Manley , I Stratton), Oxford, UK: Wiley-Blackwell, 2010.
66. Control D, Group CTR. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874.
67. Taylor-Phillips S, Mistry H, Leslie R, et al. Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. Br J Ophthalmol 2016;100:105-14.
68. Echouffo-Tcheugui J, Ali M, Roglic G, et al. Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review. Diabet Med 2013;30:1272-92.
69. Scanlon PH, Aldington SJ, Leal J, et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess 2015;19:1-116.
70. American Diabetes Association. (9) Microvascular complications and foot care. Diabetes Care 2015;38(Suppl):S58-66.
71. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001;108:572-85.
72. Lin DY, Blumenkranz MS, Brothers RJ, et al. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002;134:204-13.
73. Ahmed J, Ward TP, Bursell SE, et al. The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes care 2006;29:2205-9.
74. Roser P, Kalscheuer H, Groener JB, et al. Diabetic Retinopathy Screening Ratio Is Improved When Using a Digital, Nonmydriatic Fundus Camera Onsite in a Diabetes Outpatient Clinic. Journal of Diabetes Research 2016;2016 https://www.hindawi. com/journals/jdr/2016/4101890/cta/
75. Lopez-Bastida J, Cabrera-Lopez F, Serrano-Aguilar P. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med 2007;24:403-7.
76. Marks JB. Nonmydriatic fundus photography in screening for treatable diabetic retinopathy. J Diabetes Complicat 1992;6:247-53.
77. Taylor CR, Merin LM, Salunga AM, et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill Study. Diabetes Care 2007;30:574-8.
78. Kirkizlar E, Serban N, Sisson JA, et al. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology 2013;120:2604-10.
79. Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy-a systematic review. Diabet Med 2000; 17:495-506.
80. Moss SE, Klein R, Kessler SD, et al. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985;92:62-7.
81. Sussman EJ, Tsiaras WG, Soper KA. Diagnosis of diabetic eye disease. JAMA 1982;247:3231-4.
82. Bhargava M, Cheung CY, Sabanayagam C, et al. Accuracy of diabetic retinopathy screening by trained non-physician graders using non-mydriatic fundus camera. Singapore Med J 2012;53:715-19.
83. Gill JM, Cole DM, Lebowitz HM, et al. Accuracy of screening for diabetic retinopathy by family physicians. Ann Fam Med 2004;2:218-20.
84. Verma L, Prakash G, Tewari HK, et al. Screening for diabetic retinopathy by non-ophthalmologists: an effective public health tool. Acta Ophthalmol Scand 2003;81:373-7.
85. Kinyoun JL, Martin DC, Fujimoto WY, et al. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci 1992;33:1888-93.
86. Papavasileiou E, Dereklis D, Oikonomidis P, et al. An effective programme to systematic diabetic retinopathy screening in order to reduce diabetic retinopathy blindness. Hell J Nucl Med 2013;17:30-4.
87. Griffith SP, Freeman WL, Shaw CJ, et al. Screening for diabetic retinopathy in a clinical setting: a comparison of direct ophthalmoscopy by primary care physicians with fundus photography. J Fam Pract 1993;37:49-57.
88. Diabetic Retinopahy Grading. The University of Melbourne, Minum Barreng Indiginous Eye Health, Centre for Eye Research Australia. 2016. http://drgrading. iehu.unimelb.edu.au/cera/index.asp (accessed Nov 2016).
89. Adriono G, Wang D, Octavianus C, et al. Use of eye care services among diabetic patients in urban Indonesia. Arch Ophthalmol 2011;129:930-5.
90. Ibrahim OA, Foster A, Oluleye TS. Barriers to an effective diabetic retinopathy service in Ibadan, Nigeria (sub-Saharan Africa)-A pilot qualitative study. Ann Ib Postgrad Med 2015;13:36-43.
91. van Eijk KN, Blom JW, Gussekloo JW, et al. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. Diabetes Res Clin Pract 2012;96:10-16.
92. Hipwell AE, Sturt J, Lindenmeyer A, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening. BMJ Open 2014;4:e005498.
93. Al-Alawi A, Al-Hassan A, Chauhan D, et al. Knowledge, attitude, and perception of barriers for eye care among diabetic persons registered at Employee Health Department of a Tertiary Eye Hospital of Central Saudi Arabia. Middle East Afr J Ophthalmol 2016;23:71.
94. Zheng Y, Lamoureux EL, Chiang P-CP, et al. Language barrier and its relationship to diabetes and diabetic retinopathy. BMC public health 2012;12:781.
95. Yan X, Liu T, Gruber L, et al. Attitudes of physicians, patients, and village health workers toward glaucoma and diabetic retinopathy in rural China: a focus group study. Arch Ophthalmol 2012;130:761-70.